• Forsythoside E for PKM2 Macrophage Assays

  2026-08-27

  Forsythoside E connects PKM2 tetramerization with macrophage metabolic remodeling, making it useful for mechanism-driven inflammation and sepsis-induced liver injury research. This workflow pairs glycolysis, signaling, polarization, and target-engagement readouts instead of relying on cytokine measurements alone.

• FH1 and the Next Control Layer in Liver Research

  2026-08-27

  FH1 links iPS-derived hepatocyte maturation with a broader translational strategy: build more functional liver cell models first, then evaluate regulated gene expression in a biologically relevant context. This perspective connects FH1 (Catalog No. B3700) with the light-inducible RNA-releasing protein platform described in Trends in Biotechnology while clearly separating established findings from forward-looking research opportunities.

• IGFBP2–THBS1 Axis in GH-Mediated Bone Growth

  2026-08-26

  A 2025 study identifies an IGFBP2–THBS1 regulatory axis that helps explain how growth hormone promotes chondrocyte proliferation and hypertrophic differentiation in idiopathic short stature. Its combination of ISS-associated plasma proteomics, interaction prediction, and functional gene perturbation links GH exposure to IGF-1 pathway activity and suggests a mechanistic framework for studying variable treatment responses.

• EdU Flow Cytometry Assay Kits (Cy3) Guide

  2026-08-26

  EdU Flow Cytometry Assay Kits (Cy3) provide denaturation-free S-phase detection for RA-FLS, macrophage, cancer, and toxicology workflows. This guide connects click-chemistry DNA synthesis labeling with practical controls, multiplex design, and troubleshooting for more interpretable proliferation data.

• Liraglutide and the Brain–Kidney AVP Axis

  2026-08-25

  Greenwood and colleagues show that liraglutide lowers circulating arginine vasopressin in healthy humans and produces time- and sex-dependent synaptic phosphoproteomic changes in the rat pituitary. By combining clinical sampling, molecular profiling, an AVP luciferase assay, and renal signaling analysis, the study links GLP-1 receptor agonism to coordinated regulation of hormone release and aquaporin 2.

• Cefazedone PK/PD in Community-Acquired Pneumonia

  2026-08-25

  The reference study connected cefazedone plasma exposure, pathogen MIC values, and clinical response in patients with mild to moderate community-acquired pneumonia. Its main practical contribution was showing that 2 g every 12 hours produced a mean free-drug time above MIC of approximately 55%, supporting the studied intravenous regimen for infections caused by susceptible organisms.

• H89 Reverses ABCB1-Mediated Colorectal Cancer Resistance

  2026-08-24

  Liu and colleagues identify H89 as a potential multidrug-resistance modulator that restores sensitivity to ABCB1 substrate drugs in an HCT-8/V colorectal cancer model. Their data connect resistance reversal to impaired ABCB1 ATPase and efflux activity rather than reduced transporter expression, providing a mechanistic framework for testing combination strategies in cancer chemotherapy.

• Catalpol and the Sirt6–ERα–FasL Osteoporosis Axis

  2026-08-24

  This study identifies a mechanistic pathway by which catalpol protects ovariectomized rats from estrogen deficiency-induced osteoporosis: Sirt6-mediated ERα deacetylation increases FasL-dependent osteoclast apoptosis. Its combination of bone imaging, cellular assays, gene silencing, and co-immunoprecipitation provides a useful framework for distinguishing reduced osteoclast formation from active osteoclast elimination.

• GW 6471: PPARα Antagonist for Metabolic Research

  2026-08-23

  GW 6471 is a small molecule PPARα antagonist for mechanistic studies of receptor-dependent transcription. Its defined co-repressor mechanism supports cellular metabolism research, lipid homeostasis studies, and carefully bounded environmental toxicology experiments.

• ALDH2 Activation Delays Pressure-Overload Heart Failure

  2026-08-22

  The reference study identifies ALDH2 as more than a mitochondrial aldehyde-detoxifying enzyme: its activation promotes cardiomyocyte proliferation and extends the limited regenerative window in neonatal mice. In adult mice subjected to transverse aortic constriction, pharmacological ALDH2 activation increased cardiomyocyte proliferation and delayed pressure overload-induced heart failure, providing a mechanistic basis for further cardiac regeneration research.

• SAG, Sex-Dependent Immunity, and CNS Remyelination

  2026-08-22

  The 2024 Cells study shows that the Smoothened receptor agonist SAG promotes remyelination but modulates peripheral immunity differently in male and female demyelination models. In females, SAG-associated innate immune activation appears to limit cooperation with testosterone, highlighting sex as a critical variable in Hedgehog-based repair strategies.

• SmD2 Acetylation and PARP Sensitivity in HCC

  2026-08-21

  This study identifies acetylation-dependent control of the spliceosome core protein SmD2 as a mechanistic link between alternative splicing, BRCA1/FANC expression, DNA damage, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its findings support combining HDAC-directed treatment with PARP inhibition, while also defining important limits for transferring the mechanism to other tumor types or PARP inhibitor workflows.

• TRIM66 and Monogenic Olfactory Receptor Expression

  2026-08-20

  This study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence surplus olfactory receptor genes and maintain monogenic receptor expression. Genetic loss of Trim66 preserves low-level expression of multiple receptors, disrupts olfactory neural processing, and impairs innate olfactory behaviors, linking receptor-gene repression to sensory function.

• Methicillin Sodium Salt: MSSA Assay Workflows

  2026-08-20

  Build reproducible MSSA susceptibility, time-kill, and infection-model workflows with Methicillin sodium salt while treating MRSA resistance as an experimental variable rather than a failed assay. This guide combines concentration design, controls, endpoint selection, and troubleshooting with practical lessons from a modern phase 3 antibiotic trial.

• SmD2 Acetylation Links Splicing to PARP Inhibitor Response

  2026-08-19

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon selection, DNA damage, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its findings support combining HDAC2-axis modulation with PARP inhibition, while also defining important limits for translating the results across tumor types and experimental models.

8382 records 1/559 page Next 12345 下5页 Last page